Compare Uniphos Enter. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.83
- The company has reported losses. Due to this company has reported negative ROCE
Flat results in Dec 25
Risky - Negative EBITDA
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Aug-29-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Uniphos Enterprises Ltd is Rated Strong Sell
Uniphos Enterprises Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 02 May 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Uniphos Enterprises Ltd is Rated Strong Sell
Uniphos Enterprises Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Uniphos Enterprises Ltd Technical Momentum Shifts Amid Mixed Market Signals
Uniphos Enterprises Ltd has experienced a notable shift in price momentum, reflected in a complex blend of technical indicator signals. Despite a recent 4.97% rise in the stock price to ₹105.60, the overall technical outlook remains cautiously bearish, with key indicators such as MACD and moving averages signalling mild weakness. This nuanced scenario presents a challenging environment for investors seeking clarity on the stock’s near-term trajectory.
Read full news article Announcements 
Uniphos Enterprises Limited - Other General Purpose
05-Dec-2019 | Source : NSEUniphos Enterprises Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the SEBI (LODR) Regulations, 2015.
Shareholders meeting
20-Sep-2019 | Source : NSE
| Uniphos Enterprises Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 20, 2019. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. |
Shareholders meeting
26-Aug-2019 | Source : NSE
| Uniphos Enterprises Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 20, 2019 |
Corporate Actions 
No Upcoming Board Meetings
Uniphos Enterprises Ltd has declared 25% dividend, ex-date: 29 Aug 25
No Splits history available
No Bonus history available
Uniphos Enterprises Ltd has announced 173:100 rights issue, ex-date: 18 Sep 13
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 3 Schemes (0.0%)
Held by 15 FIIs (15.82%)
Nerka Chemicals Pvt Ltd (73.28%)
Ares Diversified (4.56%)
8.92%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -104.36% vs 3,229.73% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -82.51% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 504.31% vs -90.55% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -84.82% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,057.30% vs -95.29% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 120.16% vs 3,345.58% in Mar 2024
YoY Growth in year ended Mar 2025 is -99.27% vs -1.58% in Mar 2024






